Revvity’s EUROIMMUN business and ALPCO-GeneProof jointly announced a strategic partnership to enhance the availability of GeneProof PCR kits throughout the European Union. This collaboration brings together EUROIMMUN’s distribution network and support infrastructure with ALPCO-GeneProof's molecular diagnostic technologies.
The agreement will see EUROIMMUN delivering a comprehensive portfolio of 42 molecular diagnostic assays from ALPCO-GeneProof. These assays are based on the “one workflow” technology, which simplifies use and ensures compatibility with a broad range of qPCR instruments. Additionally, EUROIMMUN will offer the croBEE nucleic acid extraction system.
The full menu of GeneProof PCR kits includes assays for transplant and immunocompromised patients, sexually transmitted infections (STIs), bloodborne pathogens, respiratory infections, thrombotic mutations, neuroinfections, and antibiotic resistance.
